Researchers at UC Davis School of Medicine have uncovered how an imbalanced gut microbiome escalates the production of metabolic byproducts by certain gut bacteria. This imbalance drives a feedback ...

This article is part of “Innovations In: Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. The global burden of chronic kidney disease ...

With a fresh phase 3 win for Kerendia, Bayer is one step closer to pushing the ascendant drug into a much broader population of patients with chronic kidney disease (CKD). Kerendia, also known as ...

Finerenone significantly improves eGFR slope in patients with nondiabetic chronic kidney disease, suggesting a slowed progression of renal decline. Topline results were announced from a phase 3 trial ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD). The ...

"Real Housewives of New York City" alumna Bethenny Frankel is encouraging people to "be mindful" about their health as she reveals a recent medical diagnosis. The 55-year-old entrepreneur shared in a ...

CKD is a significant nontraditional risk factor for CVD, affecting 10% of the global population and increasing cardiovascular morbidity and mortality. Cardiovascular risk in CKD patients begins early ...

Aprocitentan (Tryvio; Idorsia Pharmaceuticals), which targets the endothelin pathway, can safely lower blood pressure in patients with chronic kidney disease (CKD) and resistant hypertension, ...

CKD prevalence has more than doubled since 1990, with 788 million adults affected in 2023, highlighting a significant global health challenge. The disease is a major contributor to cardiovascular ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...

The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million worldwide, according to new research published in The Lancet. The findings ...